FGF7, fibroblast growth factor 7, 2252

N. diseases: 167; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.100 GeneticVariation disease GWASCAT Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. 28604730 2017
Thyroid stimulating hormone measurement
0.100 GeneticVariation phenotype GWASCAT A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. 23408906 2013
Thyroid stimulating hormone measurement
0.100 GeneticVariation phenotype GWASDB A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. 23408906 2013
CUI: C0441683
Disease: Hormone measurement
Hormone measurement
0.100 GeneticVariation group GWASCAT A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. 23408906 2013
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.040 GeneticVariation disease BEFREE This study aimed to investigate the association between FGF7 polymorphisms with COPD susceptibility in a Chinese Han population. 22796760 2012
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.040 GeneticVariation disease BEFREE In this study, we replicated the genetic association of variants near the FGF7 gene in 258 Chinese Han patients with COPD and 311 healthy controls. 30777021 2019
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.040 GeneticVariation disease BEFREE After applying the weights constructed from these regions to a collaborative GWAS of COPD, the authors identified two single nucleotide polymorphisms (SNPs) in a novel gene (fibroblast growth factor-7 (FGF7)) that gained genome-wide significance by the false discovery rate method. 21921092 2011
CUI: C0521585
Disease: Gastrointestinal mucositis
Gastrointestinal mucositis
0.040 GeneticVariation disease BEFREE Palifermin, a recombinant form of the human keratinocyte growth factor can avoid mucositis in patients treated with myeloablative polychemotherapy for allogeneic stem cell transplantation. 16923516 2006
CUI: C0006287
Disease: Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia
0.030 GeneticVariation disease BEFREE Fibroblast growth factor 7 (FGF7) and FGF10 signaling in the lung through FGF receptor 2 (FGFR2) are involved in epithelial cell protection and renewal, and mutations in their corresponding genes in humans are linked to increased susceptibility to lung pathologies, such as chronic obstructive pulmonary disease and bronchopulmonary dysplasia. 29722558 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.020 GeneticVariation group BEFREE Interactions between infiltrating T cells and keratinocytes via the secretion of the TH1 cytokines interleukin (IL) 2 and interferon gamma (INF-gamma), the keratinocyte growth factor transforming growth factor alpha (TGF-alpha) and the cytokines IL-6 and IL-8 are thought to be the predominant mechanisms inducing skin lesions in psoriatic patients. 9767281 1998
CUI: C0015967
Disease: Fever
Fever
0.010 GeneticVariation phenotype BEFREE The two adverse events assessed as related to KGF were due to pyrexia. 28526233 2017
CUI: C1704272
Disease: Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
0.340 Biomarker disease CTD_human It is concluded that upregulated ERalpha in prostatic stroma may have a greater modulating influence on synthesis of certain growth factors than the direct action of androgens and, by enhancing synthesis of FGF-2 and FGF-7, could play a significant role in the development of BPH. 14999240 2004
CUI: C1704272
Disease: Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
0.340 Biomarker disease BEFREE Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia. 18386288 2008
CUI: C1704272
Disease: Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
0.340 Biomarker disease BEFREE Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia. 10902811 2000
CUI: C1704272
Disease: Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
0.340 Biomarker disease BEFREE Although the mechanism by which the drugs cause GO is not yet understood, keratinocyte growth factor (KGF), which is a potent epithelial cell mitogen, has been implicated in other hyperplastic conditions, including mammary and prostatic hyperplasia, and could also be involved in the molecular pathology of GO. 11453236 2001
CUI: C0023890
Disease: Liver Cirrhosis
Liver Cirrhosis
0.320 Biomarker disease CTD_human Differential regulated expression of keratinocyte growth factor and its receptor in experimental and human liver fibrosis. 17692400 2007
CUI: C0034069
Disease: Pulmonary Fibrosis
Pulmonary Fibrosis
0.320 Biomarker disease CTD_human We evaluated in vitro KGF production by human lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF, n = 10) and from control subjects (n = 7) at baseline and after IL-1beta stimulation. 15677771 2005
CUI: C0034069
Disease: Pulmonary Fibrosis
Pulmonary Fibrosis
0.320 Biomarker disease BEFREE KGF expressing adenovirus vector, which prevented bleomycin-induced pulmonary fibrosis in a previous study, was constructed. 28543309 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.320 Biomarker disease CTD_human This study was designed to characterize a putative role of KGF in observed histomorphological changes in both, human and experimental liver fibrosis. 17692400 2007
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.320 Biomarker disease BEFREE This study was designed to characterize a putative role of KGF in observed histomorphological changes in both, human and experimental liver fibrosis. 17692400 2007
CUI: C2937421
Disease: Prostatic Hyperplasia
Prostatic Hyperplasia
0.320 Biomarker disease LHGDN Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia. 18386288 2008
CUI: C2937421
Disease: Prostatic Hyperplasia
Prostatic Hyperplasia
0.320 Biomarker disease CTD_human Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone. 14999240 2004
CUI: C2937421
Disease: Prostatic Hyperplasia
Prostatic Hyperplasia
0.320 Biomarker disease BEFREE Although the mechanism by which the drugs cause GO is not yet understood, keratinocyte growth factor (KGF), which is a potent epithelial cell mitogen, has been implicated in other hyperplastic conditions, including mammary and prostatic hyperplasia, and could also be involved in the molecular pathology of GO. 11453236 2001
CUI: C0008924
Disease: Cleft upper lip
Cleft upper lip
0.310 Biomarker disease CTD_human Sequence evaluation of FGF and FGFR gene conserved non-coding elements in non-syndromic cleft lip and palate cases. 17963255 2007
CUI: C0008924
Disease: Cleft upper lip
Cleft upper lip
0.310 Biomarker disease LHGDN Impaired FGF signaling contributes to cleft lip and palate. 17360555 2007